Funded Biomarker Testing
1 items
Repeat FLT3 testing of adult patients with relapsed or refractory acute myeloid leukemia being considered for therapy with Gilteritinib.
Funded Biomarker Disease Site: Hematology
Biomarker: FLT3
Testing Method:Sequencing
Testing Site: Hamilton Health Sciences, Health Sciences North, Kingston Health Sciences Centre, London Health Sciences Centre, St. Joseph's Healthcare Hamilton, The Ottawa Hospital, University Health Network